Lantheus Holdings Inc
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceut… Read more
Market Cap & Net Worth: Lantheus Holdings Inc (LNTH)
Lantheus Holdings Inc (NASDAQ:LNTH) has a market capitalization of $5.21 Billion ($5.21 Billion) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #2962 globally and #2004 in its home market, demonstrating a 8.19% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Lantheus Holdings Inc's stock price $78.50 by its total outstanding shares 66311779 (66.31 Million).
Lantheus Holdings Inc Market Cap History: 2015 to 2026
Lantheus Holdings Inc's market capitalization history from 2015 to 2026. Data shows growth from $224.13 Million to $5.21 Billion (34.02% CAGR).
Index Memberships
Lantheus Holdings Inc is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.20% | #64 of 976 |
|
NASDAQ Composite
IXIC
|
$33.26 Trillion | 0.01% | #359 of 3165 |
|
S&P Midcap 400
MID
|
$3.04 Trillion | 0.27% | #266 of 401 |
Weight: Lantheus Holdings Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Lantheus Holdings Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Lantheus Holdings Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.86x
Lantheus Holdings Inc's market cap is 2.86 times its annual revenue
1.01x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
18.89x
Lantheus Holdings Inc's market cap is 18.89 times its annual earnings
10.29x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $570.28 Million | $301.85 Million | $26.76 Million | 1.89x | 21.31x |
| 2017 | $1.36 Billion | $331.38 Million | $123.39 Million | 4.09x | 10.99x |
| 2018 | $1.04 Billion | $343.37 Million | $40.52 Million | 3.02x | 25.61x |
| 2019 | $1.36 Billion | $347.34 Million | $31.67 Million | 3.92x | 42.95x |
| 2020 | $894.55 Million | $339.41 Million | -$13.47 Million | 2.64x | N/A |
| 2021 | $1.92 Billion | $425.21 Million | -$71.28 Million | 4.51x | N/A |
| 2022 | $3.38 Billion | $935.06 Million | $28.07 Million | 3.61x | 120.40x |
| 2023 | $4.11 Billion | $1.30 Billion | $326.66 Million | 3.17x | 12.59x |
| 2024 | $5.93 Billion | $1.53 Billion | $312.44 Million | 3.87x | 18.99x |
| 2025 | $4.41 Billion | $1.54 Billion | $233.56 Million | 2.86x | 18.89x |
Competitor Companies of LNTH by Market Capitalization
Companies near Lantheus Holdings Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Lantheus Holdings Inc by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Lantheus Holdings Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Lantheus Holdings Inc's market cap moved from $224.13 Million to $ 5.21 Billion, with a yearly change of 34.02%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $5.21 Billion | +17.96% |
| 2025 | $4.41 Billion | -25.61% |
| 2024 | $5.93 Billion | +44.29% |
| 2023 | $4.11 Billion | +21.66% |
| 2022 | $3.38 Billion | +76.39% |
| 2021 | $1.92 Billion | +114.16% |
| 2020 | $894.55 Million | -34.23% |
| 2019 | $1.36 Billion | +31.05% |
| 2018 | $1.04 Billion | -23.47% |
| 2017 | $1.36 Billion | +137.79% |
| 2016 | $570.28 Million | +154.44% |
| 2015 | $224.13 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Lantheus Holdings Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.21 Billion USD |
| MoneyControl | $5.21 Billion USD |
| MarketWatch | $5.21 Billion USD |
| marketcap.company | $5.21 Billion USD |
| Reuters | $5.21 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.